# Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

> **NCT01519011** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 34 (actual)

## Conditions studied

- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myeloid, Acute

## Interventions

- **DRUG:** oral azacitidine
- **DRUG:** oral azacitidine

## Key facts

- **NCT ID:** NCT01519011
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-07
- **Primary completion:** 2012-12-31
- **Final completion:** 2015-05-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519011, "Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01519011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*